Immunoblotting and immunofluorescence staining revealed that the levels of NET markers (CitH3, MPO, and PAD4) were higher in patients with AAA than in healthy individuals (Supplementary Fig. 2b, c). This evidence concerns the gene MPO and triple-A syndrome.